Company Search:
Advanced Search
Sponsored Links
Oriola Oyj Company Snapshot
Oriola Oyj operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oriola Oyj with three other drug stores in Europe: Selcuk Ecza Deposu Ticaret ve Sanayi AS of Turkey (2017 sales of 10.69 billion Turkish Liras [US$2.03 billion] of which 100% was Medical and Hospital Equipment), Neuca SA of Poland (7.49 billion Polish New Zlotys [US$1.96 billion] of which 99% was Pharmaceutical Wholesale), and Udg Healthcare Plc which is based in Ireland (1.10 billion Euro [US$1.24 billion] of which 67% was Ashfield).

Sales Analysis. During the year ended December of 2017, sales at Oriola Oyj were 1.53 billion Euro (US$1.73 billion). This is a decrease of 7.0% versus 2016, when the company's sales were 1.64 billion Euro. Contributing to the drop in overall sales was the 3.8% decline in Consumer, from 811.50 million Euro to 780.30 million Euro. There were also decreases in sales in Services (down 3.4% to 2.48 billion Euro) . However, these declines were partially offset by the increase in sales of Healthcare (up 95.9% to 71.10 million Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oriola Oyj
  Stock Performance Chart for Oriola Oyj
  Stock Data: Recent Stock Performance:
  Current Price (2/8/2019): 2.09
(Figures in Euro)
1 Week -4.4%   13 Weeks -7.5%  
4 Weeks -17.9%   52 Weeks -22.2%  
Oriola Oyj Key Data:
  Ticker: OKDBV Country: Finland
  Exchanges: HEL Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2017 Sales 1,527,700,000
(Year Ending Jan 2018).
Employees: 2,619
  Currency: Euro Market Cap: 378,182,387
  Fiscal Yr Ends: December Shares Outstanding: 181,382,440
  Share Type: Osake B Closely Held Shares: 46,442,355
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.